About
Novel, clinical-stage synthetic cannabinoid product pipeline for dermatology and antimicrobial indications
Areas of Focus
Categories
Small Molecule PharmaceuticalCannabis & MarijuanaDrug Delivery & FormulationAustralia
Team (10)
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
2,102
By Phase
PHASE3: 3PHASE2: 6PHASE1: 1
By Status
COMPLETED: 11
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT03948646Lead Sponsor
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
PHASE3Completed
351 participants
Started: Dec 4, 2020 · Completed: Aug 13, 2021
NCT03836287Lead Sponsor
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)
PHASE3Completed
350 participants
Started: Oct 9, 2020 · Completed: Jun 25, 2021
NCT03824405Lead Sponsor
Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis
PHASE2Completed
200 participants
Started: Feb 4, 2019 · Completed: Mar 4, 2020
NCT03785587Lead Sponsor
A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis
PHASE2Completed
21 participants
Started: Dec 21, 2018 · Completed: Sep 6, 2019
NCT03627468Lead Sponsor
A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis
PHASE3Completed
300 participants
Started: Sep 5, 2018 · Completed: Jan 27, 2020
Locations (1)
Headquarters
West Perth, Australia
Map
Loading map...